Harsh Michael's most recent trade in ENDRA Life Sciences Inc was a trade of 5,384 Common Stock done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ENDRA Life Sciences Inc | Michael Harsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 5,384 | 5,386 | - | 0 | Common Stock | |
| ENDRA Life Sciences Inc | Harsh Michael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 600 | 600 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Michael Harsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 9,634 | 9,634 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Michael Harsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 109,492 | 109,492 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Michael Harsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 12,000 | 12,000 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Michael Harsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2021 | 25,000 | 25,000 | - | - | Stock Options |